LU85744A1 - Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6,un procede pour leur preparation et compositions therapeutiques a base de ces derives - Google Patents

Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6,un procede pour leur preparation et compositions therapeutiques a base de ces derives Download PDF

Info

Publication number
LU85744A1
LU85744A1 LU85744A LU85744A LU85744A1 LU 85744 A1 LU85744 A1 LU 85744A1 LU 85744 A LU85744 A LU 85744A LU 85744 A LU85744 A LU 85744A LU 85744 A1 LU85744 A1 LU 85744A1
Authority
LU
Luxembourg
Prior art keywords
furo
pyridine
hydroxy
dihydro
derivatives
Prior art date
Application number
LU85744A
Other languages
English (en)
French (fr)
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of LU85744A1 publication Critical patent/LU85744A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
LU85744A 1984-02-02 1985-01-25 Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6,un procede pour leur preparation et compositions therapeutiques a base de ces derives LU85744A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives
GB8402740 1984-02-02

Publications (1)

Publication Number Publication Date
LU85744A1 true LU85744A1 (fr) 1985-07-24

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85744A LU85744A1 (fr) 1984-02-02 1985-01-25 Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6,un procede pour leur preparation et compositions therapeutiques a base de ces derives

Country Status (24)

Country Link
US (1) US4581362A (sv)
JP (1) JPS60181088A (sv)
AT (1) AT391700B (sv)
BE (1) BE901545A (sv)
CA (1) CA1300148C (sv)
CH (1) CH663023A5 (sv)
DE (1) DE3503435A1 (sv)
DK (1) DK158951C (sv)
DZ (1) DZ743A1 (sv)
ES (1) ES8607308A1 (sv)
FI (1) FI82051C (sv)
FR (2) FR2559062B1 (sv)
GB (1) GB8402740D0 (sv)
HK (1) HK92587A (sv)
IE (1) IE58229B1 (sv)
IT (1) IT1200587B (sv)
LU (1) LU85744A1 (sv)
MA (1) MA20342A1 (sv)
NL (1) NL8500241A (sv)
NO (1) NO160369C (sv)
OA (1) OA07947A (sv)
PT (1) PT79913B (sv)
SE (2) SE460903B (sv)
ZA (1) ZA85508B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
PE20221914A1 (es) 2011-12-28 2022-12-23 Global Blood Therapeutics Inc Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN112500338A (zh) 2013-03-15 2021-03-16 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR101971385B1 (ko) 2013-03-15 2019-04-22 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
AU2015214182B2 (en) 2014-02-07 2020-04-30 Global Blood Therapeutics, Inc. Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020072377A1 (en) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (sv) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
NL8500241A (nl) 1985-09-02
OA07947A (fr) 1987-01-31
JPS60181088A (ja) 1985-09-14
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
CA1300148C (en) 1992-05-05
FI850275A0 (fi) 1985-01-22
FI82051B (fi) 1990-09-28
NO160369C (no) 1989-04-12
DK158951C (da) 1990-12-31
SE460903B (sv) 1989-12-04
FR2559152A1 (fr) 1985-08-09
PT79913B (en) 1986-11-10
AT391700B (de) 1990-11-12
ZA85508B (en) 1985-11-27
DK158951B (da) 1990-08-06
IE58229B1 (en) 1993-08-11
FR2559062B1 (fr) 1987-05-22
DK45585D0 (da) 1985-02-01
FR2559152B1 (fr) 1987-05-22
CH663023A5 (fr) 1987-11-13
FR2559062A1 (fr) 1985-08-09
DE3503435A1 (de) 1985-08-08
SE8500460L (sv) 1985-08-03
JPH0240069B2 (sv) 1990-09-10
IT1200587B (it) 1989-01-27
BE901545A (fr) 1985-07-22
IT8519327A0 (it) 1985-02-01
PT79913A (en) 1985-03-01
NO160369B (no) 1989-01-02
FI82051C (sv) 1991-01-10
ES540080A0 (es) 1986-05-16
SE8500460D0 (sv) 1985-02-01
DK45585A (da) 1985-08-03
GB8402740D0 (en) 1984-03-07
MA20342A1 (fr) 1985-10-01
US4581362A (en) 1986-04-08
DE3503435C2 (sv) 1991-11-07
IE850241L (en) 1985-08-02
HK92587A (en) 1987-12-11
DZ743A1 (fr) 2004-09-13
NO850399L (no) 1985-08-05
ATA27585A (de) 1990-05-15

Similar Documents

Publication Publication Date Title
LU85744A1 (fr) Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6,un procede pour leur preparation et compositions therapeutiques a base de ces derives
FR2555049A1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
JPH04338383A (ja) 置換されたベンゾキサゼピン類及びベンゾチアゼピン類
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
EP0148167A2 (fr) Nouveaux dérivés de la quinoléine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
CA2022732A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0002978A2 (fr) Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique
FR2669633A1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CH666688A5 (fr) Procede de preparation des derives de la furo-(3,4-c)-pyridine substituees en position 6.
FR2553286A1 (fr) Compositions therapeutiques a base de nouveaux derives de la chloro-4-furo-(3,4-c)-pyridine
FR2572405A1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
EP0027759B1 (fr) Nouveaux dérivés spiranniques, procédé pour leur préparation, et médicaments les contenant
FR2465733A1 (fr) Nouveaux derives imidazolylethoxymethyliques de 1,3-dioxoloquinoleines utiles notamment comme medicaments antibacteriens et antifongiques, leur procede de preparation et compositions therapeutiques et formes pharmaceutiques les contenant
EP0136198A1 (fr) Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques
EP0581767B1 (en) 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS
FR2503140A1 (fr) Acides biphenyl-4 oxo-4 methylene-3 butyriques, leur procede de preparation et leur utilisation comme medicaments
EP0168288B1 (fr) Nouveaux dérivés de l'aminométhyl-6 furo-(3,4-c)-pyridine, leur procédé de préparation et compositions thérapeutiques les contenant
FR2475543A1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
JPH04221386A (ja) 4H−ピロロ[1,2−a]チエノ[2,3−f][1,4]ジアゼピンの新規誘導体、それらの製造方法及びこれらを含有する医薬品組成物
EP0982308B1 (fr) Dérivés de 8H-(2,3-b)-pyrrolizine-8-one, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US5508280A (en) 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
CH615171A5 (sv)
LU86053A1 (fr) Nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques en contenant
KR830000387B1 (ko) 이소옥사졸 유도체의 제조방법
JP3018573B2 (ja) ベンズアゼピノピリダジン化合物